After a specimen has been held for 48 hours, which test is more specific for diagnosing PML‑RARA in acute promyelocytic leukaemia, RT‑PCR or FISH?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

FISH is More Specific After 48 Hours

After a specimen has been held for 48 hours, FISH is the more specific test for diagnosing PML-RARA in acute promyelocytic leukemia because RT-PCR samples must be processed within 24 hours to avoid RNA degradation, whereas FISH samples remain stable at ambient temperature and can be stored at -20°C indefinitely. 1

Critical Sample Stability Differences

The European LeukemiaNet guidelines explicitly state that RT-PCR samples require processing within 24 hours, making them unreliable after 48 hours of storage. 1 In contrast:

  • FISH samples can be sent at ambient temperature and stored at -20°C covered by aluminum paper without time constraints 1
  • RT-PCR samples deteriorate rapidly—poor RNA yield leads to false negatives, which is a major drawback of this methodology 1
  • After 48 hours, RNA degradation in RT-PCR samples compromises the assay's reliability, effectively eliminating its diagnostic value 1

Comparative Specificity Under Optimal Conditions

When both tests are performed under ideal conditions (fresh samples), the guidelines state that "all of the aforementioned options are equally specific" 1. However, this equivalence only applies when samples are processed appropriately:

  • RT-PCR is described as the "gold standard" with high specificity and sensitivity when RNA is fresh 1
  • FISH maintains equally high specificity and sensitivity regardless of sample age 1
  • Both techniques are "highly efficient to confirm the diagnosis of APL" in terms of specificity 1

Practical Algorithm for 48-Hour-Old Samples

Use FISH exclusively when the specimen has been held for 48 hours because:

  • RT-PCR will likely yield false negatives due to RNA degradation 1
  • FISH maintains diagnostic accuracy on stored smears 1
  • FISH can detect cryptic rearrangements and insertions that might be missed by degraded RNA samples 1

Important Caveats About FISH Limitations

While FISH is superior for delayed samples, be aware of these technical limitations:

  • FISH cannot detect the PML-RARA isoform type (bcr1, bcr2, bcr3), which is essential for minimal residual disease monitoring 1
  • Small PML-RARA insertions may be missed when using very large probes—use relatively small cosmid probes instead 1
  • FISH will miss cases where RARA-PML is deleted or where PML-RARA forms as a result of insertion 1
  • FISH provides no information about breakpoint location needed for MRD evaluation 1

Clinical Impact on Patient Outcomes

The 48-hour delay has critical implications for mortality and morbidity:

  • APL has a high early death rate from hemorrhagic complications that occur before diagnosis 1
  • Delayed or inaccurate diagnosis prevents timely initiation of ATRA therapy, which is lifesaving 1
  • Using the wrong test on a 48-hour-old sample risks false-negative results, delaying treatment and increasing mortality 1

Optimal Diagnostic Strategy

For specimens older than 24 hours, perform FISH immediately to confirm PML-RARA and start ATRA therapy without delay. 1 Once the patient is stabilized, collect fresh samples for RT-PCR to:

  • Define the PML-RARA isoform for subsequent MRD monitoring 1
  • Establish the molecular target for long-term follow-up 1
  • Confirm the diagnosis with the gold-standard methodology 1

The European LeukemiaNet explicitly recommends that "these techniques should not replace RT-PCR" for complete diagnostic workup, but this applies only when fresh samples are available. 1 After 48 hours, FISH becomes the only reliable option for confirming PML-RARA positivity and guiding immediate treatment decisions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.